Top UK Court To Weigh Pfizer Costs Bid In £89M Antitrust Suit
Britain's highest court has agreed to decide whether Pfizer and Flynn Pharma can recover their legal fees from the country's competition watchdog after beating its initial £89.4 million ($122 million) case...To view the full article, register now.
Already a subscriber? Click here to view full article